In cold tumors, tumor cells within the TME always express diverse immunosuppressive ligands, such as PD-L1 and CTLA-4, to inhibit antitumor immunity, resulting in a lack of immunogenicity and immune cell infiltration [31]. This evidence concerns the gene CTLA4 and neoplasm.